Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by Odelayon Apr 18, 2018 8:41pm

131 Views

Post# 27908274

RE:RE:RE:RE:RE:Thoughts on close?

I bought back on Feb 5th when we bounced off the 100. But it was short lived, so I jumped back out. I got in March 6th and out on the 13th, so I missed the run to 41 plus.

I try to not get emotionally involved with companies, which is hard with KALY. I realy think we have a winner here, so I am trying my best to play by my own system and not buy because I want to buy. The fact that the 200 and the 8 day EMA (my Bible) are basically alligned means that I will defintiely be in tomorrow if we can get over .215.

Here's hoping! Good luck to you! I don't think opportunities like this come around that often. Let's make the most of it.

Bullboard Posts

Changing Europe’s dependency on HREE from China